Obstruction-driven HFpEF in hypertrophic cardiomyopathy: a multimodal, guideline-based approach

10 May 2026 (10:41 - 10:52)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Florin Giru

Institute of Cardiovascular and Heart Diseases of Timisoara, Timisoara (Romania)

3 More presentations in this session

Presentation thumbnail

Progressive fibrosis burden and primary prevention ICD decision in hypertrophic cardiomyopathy: a genetics- and imaging-based case

Doctor O. Gok (Istanbul, TR)

Presentation thumbnail

Unmasking hypertrophic cardiomyopathy in women: the challenge of early detection

Doctor M. Barki (Milan, IT)

Presentation thumbnail

The thinner the better? A journey through the clinical evolution of hypertrophic cardiomyopathy

Doctor A. Parodi (Padova, IT)

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk

The Event

Event poster

Heart Failure 2026

10 May 2026 10:41 CET

You may be interested in

Congress Presentation

Effects of Mavacamten use in a patient with hypertrophic obstructive cardiomyopathy and extremely high resting left ventricular outflow tract gradient

Congress Presentation

Mavacamten therapy in hypertrophic obstructive cardiomyopathy revealing severe aortic stenosis: a case highlighting diagnostic complexity

Congress Session

Myosin inhibition in hypertrophic cardiomyopathy: beyond the classic left ventricular outflow tract story

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources